Transitional Cell Carcinoma Completed Phase 2 Trials for Vinflunine (DB11641)

Also known as: Carcinoma, Transitional Cell / Carcinoma transitional cell / Transitional cell carcinoma (morphologic abnormality)

IndicationStatusPhase
DBCOND0031000 (Transitional Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01529411Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial CancerTreatment
NCT00101608Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumTreatment